Chronic Fatigue Syndrome in Psychiatric Patients

References

• Shafran SD. The chronic fatigue syndrome. Am J Med, 1991; 90:730–739.
   PubMed Web of Science ®Google Scholar
• Klonoff DC. Chronic fatigue syndrome. Clin Infect Dis, 1993; 26: 823–834.
   Google Scholar
• Lane RM. Aetiology, diagnosis and treatment of chronic fatigue syndrome. J Serotonin Res, 1994; 1:47–60.
   Google Scholar
• Farrar DJ, Locke SE, Kantrowitz FG. Chronic fatigue syndrome 1: etiology and pathogenesis. Behav Med, 1995; 21: 5–16.
   Google Scholar
• Mechanic D. Discussion of Manu P, Lane TJ, Matthews DA. Chronic fatigue and chronic fatigue syndrome: clinical epidemiology and aetiological classification. In Chronic Fatigue Syndrome. Chichester: Wiley (Ciba Found Symp 173) 1993; p. 34.
   Google Scholar
• Endicott NA. Chronic fatigue syndrome in psychiatric patients: life-time and premorbid personal history of physical health. Psychosom Med, 1998; 60: 744–751.
   PubMed Web of Science ®Google Scholar
• Endicott NA. Chronic fatigue syndrome in psychiatric patients: evidence of premorbid anomalous patterns of brain organization. J Chronic Fatigue Syndrome, 1999; 5: 29–45.
   Google Scholar
• Endicott NA. Chronic fatigue syndrome in private practice psychiatry: family history of physical and mental health. J Psychosom Res, 1999; 47: 343–354.
   PubMed Web of Science ®Google Scholar
• Buchwald D, Garrity D. Comparisons of patients with chronic fatigue syn-drome, fibromyalgia, and multiple chemical sensitivities. Arch Int Med, 1994; 154: 2049–2053.
   PubMed Web of Science ®Google Scholar
• Chester AC, Levine PH. Concurrent sick building syndrome and chronic fa-tigue syndrome: epidemic neuromyasthenia revisited. Clin Infect Dis, 1994; 18 (Suppl 1): 543–548.
   Google Scholar
• Dunstan R, Donohoe M, Taylor W, Roberts T, Murdock R, Watkins J, McGregor N. A preliminary investigation of chlorinated hydrocarbons and chronic fatigue syn-drome. Med J Australia, 1995; 163: 294–297.
   Google Scholar
• Fiedler N, Kipen H, DeLuca J, Kelly-McNeil K, Natelson B. A controlled com-parison of multiple chemical sensitivities and chronic fatigue syndrome. Psychosom Med, 1996; 58: 38–49.
   Google Scholar
• Chaudhari A, Majeed T, Dinan T, Behan P. Chronic fatigue syndrome: a disor-der of central cholinergic transmission. J Chronic Fatigue Syndrome, 1997; 3: 3–16.
   Google Scholar
• Bell IR, Baldwin CM, Schwartz GE. Illness from low levels of environmental chemicals: relevance to chronic fatigue syndrome and fibromyalgia. Am J Med, 1998; 105 (3A): 74S–82S.
   Google Scholar
• Vojdani A, Lapp CW. The relationship between chronic fatigue syndrome and chemical exposure. J Chronic Fatigue Syndrome 1999; 5: 207–208.
   Google Scholar
• Keller RH, Lane JL, Klimas N, Reiter WM, Fletcher MA, Van Riel F, Morgan R. Association between HLA class II antigens and the chronic fatigue immune dys-function syndrome. Clin Infect Dis, 1994; (Suppl 1): S 154-5 156.
   Google Scholar
• Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med, 1988; 108: 387–389.
   PubMed Web of Science ®Google Scholar
• Schluederberg A, Straus SE, Peterson P, et al. Chronic fatigue syndrome re-search: Definition and medical outcome assessment. Ann Intern Med, 1992; 117: 325–331.
   PubMed Web of Science ®Google Scholar
• Fukuda K, Straus SE, Hickie I, et al. and the International Chronic Fatigue Syn-drome Study Group. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med, 1994; 121: 953–959.
   Google Scholar
• Miller CS. White paper: chemical sensitivity: history and phenomenology. Toxicol Ind Health, 1994; 10: 253–276.
   PubMed Web of Science ®Google Scholar
• Ashford N, Miller CS. Chemical Exposures: Low Levels and High Stakes. Sec-ond Edition. New York: John Wiley and Sons, Inc., 1998.
   Google Scholar
• Bell IR, Miller CS, Schwartz GE. An olfactory-limbic model of multiple chem-ical sensitivity syndrome: possible relationship to kindling and affective spectrum dis-orders. Biol Psychiat, 1992; 32: 218–242.
   Google Scholar
• Bell IR. Neuropsychiatric aspects of sensitization to low level chemicals: a neu-ral sensitization model. Toxicol Ind Health 1994; 10: 277–312.
   PubMed Web of Science ®Google Scholar
• Demitrack MA, Abbey SE. Historical overview and evolution of contemporary defmitions of chronic fatigue states. In: Demitrack MA, Abbey SE, eds., Chronic Fa-tigue Syndrome: An Integrative Approach to Evaluation and Treatment. New York: Guilford Press, 1996, pp. 3–35.
   Google Scholar
• Kalivas PW, Barnes CD (eds.). Sensitization in the Nervous System. New Jer-sey: Telford Press, 1988.
   Google Scholar
• Joy RM. Mode of action of lindane, dieldrin, and related insecticides in the cen-tral nervous system. Neurobehav Toxicol Teratol, 1982; 4: 813–823.
   PubMedGoogle Scholar
• Gilbert ME. Repeated exposures to lindane leads to behavioral sensitization and facilitates electrical kindling. Neurotoxicol Teratol, 1995; 17: 131–141.
   PubMed Web of Science ®Google Scholar
• Burchfiel JL, Duffy FH. Organophosphate neurotoxicity: chronic effects of sarin on the electroencephalogram of monkey and man. Neurobehav Toxicol Teratol, 1982; 4: 767–778.
   PubMedGoogle Scholar
• Sorg BA, Willis JR, Nowatka TC, et al. A proposed animal neurosensitization model for multiple chemical sensitivity in studies with formalin. Toxicology, 196; 111: 135–145.
   Google Scholar
• Kay LM. Support for the kindling hypothesis in multiple chemical sensitivity syndrome (MESS) induction. Soc Neurosci, 1996; 22: 1825.
   Google Scholar
• Sorg BA, Willis JR, See RE, et al. Repeated low-level formaldehyde exposure produces cross-sensitization to cocaine: possible relevance to chemical sensitivity in humans. Neuropsychopharmacology, 1998; 18: 385–394.
   PubMed Web of Science ®Google Scholar
• Newlin CB, Thomson JB. Chronic tolerance and sensitization to alcohol in sons of alcoholics. Alcohol Clin Exp Res, 1991; 15: 399–405.
   PubMed Web of Science ®Google Scholar
• Antelman SM, Caggiula AR, Kocan D, et al. One experience with 'lower' or 'higher' intensity stressors respectively enhances or diminishes responsiveness to haloperidol weeks later: implications for understanding drug variability. Brain Res, 1991; 566: 276–283.
   PubMed Web of Science ®Google Scholar
• Antelman SM. Time-dependent sensitization as the cornerstone for a new ap-proach to pharmacotherapy: drugs as foreign/stressful stimuli. Drug Devel Res, 1988; 14: 1–30.
   Web of Science ®Google Scholar
• Antelman SM. Time-dependent sensitization in animals: a possible model of multiple chemical sensitivity in humans. Toxicol Ind Health, 1994; 10:335–342.
   PubMed Web of Science ®Google Scholar
• Kalivas PW, Richardson-Carlson R, van Orden G. Cross-sensitization between foot shock stress and enkephalin-induced motor activity. Biol Psychiatry, 1986; 21: 939–950.
   PubMed Web of Science ®Google Scholar
• Cain DP, Corcoran ME. Intracerebral beta-endorphin, met-enkephalin and morphine: kindling of seizures and handling-induced potentiation of epileptiform ef-fects. Life Sci, 1984; 34: 2535–2542.
   PubMed Web of Science ®Google Scholar
• Vezina P. Kalivas PW, Stewart J. Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeat-edly to the ventral tegmental area but not to the nucleus accumbens. Brain Res, 1987; 417: 51–58.
   Google Scholar
• Denicoff KD, Kurkin TM, Lotze MT, et al. The neuroendocrine effects of interleukin-2 treatment. J Clin Endocrinol Metab, 1989; 69:402–410.
   PubMed Web of Science ®Google Scholar
• Zalcman S, Green-Johnson IM, Murray L, et al. Cytokine-specific central monoamine alterations induced by interleukin-1,-2, and -6. Brain Res, 1994; 643: 40–49.
   PubMed Web of Science ®Google Scholar
• Deroche V, Piazza PV, Maccari S, et al. Repeated corticosterone administration sensitizes the locomotor response to amphetamine. Brain Res, 1992; 584: 309–313.
   PubMed Web of Science ®Google Scholar
• Antelman SM, Eichler AJ, Black CA, et al. Interchangeability of stress and am-phetamine in sensitization. Science, 1980; 207: 329–331.
   PubMed Web of Science ®Google Scholar
• Antelman SM, Kocan D, Knopf S, et al. One brief exposure to a psychological stressor induces long-lasting, time-dependent sensitization of both the cataleptic and neurochemical responses to haloperidol. Life Sci, 1992; 51: 261–266.
   PubMed Web of Science ®Google Scholar
• Reyes M, Dobbins JG, Mawle AC, et al. Risk factors for chronic fatigue syn-drome: a case-control study. J Chronic Fatigue Syndrome, 1996; 4: 17–33.
   Google Scholar
• Abbey SE, Garfinkel PE. Neurasthenia and chronic fatigue syndrome: the role of culture in making of a diagnosis. Am J Psychiat, 1991; 148: 1638–1646.
   PubMed Web of Science ®Google Scholar
• Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab, 1991; 73: 1224–1234.
   PubMed Web of Science ®Google Scholar
• Demitrack MA. Chronic fatigue syndrome: a disease of the hypothalamic-pitu-itary-adrenal axis? Ann Med, 1994; 26: 1–5.
   Google Scholar
• Bou-Holaigah I, Rowe PC, Kan J, et al. The relationship between neurally me-diated hypotension and the chronic fatigue syndrome. JAMA, 1995; 274: 961–967.
   Google Scholar
• Goldstein JA. Chronic Fatigue Syndrome: The Limbic Hypothesis. New York: The Haworth Press, Inc., 1993.
   Google Scholar
• Goldstein JA. Betrayal by the Brain: The Neurologic Basis of Chronic Fatigue Syndrome, Fibromyalgia Syndrome, and Related Neural Network Disorders. New York: The Haworth Press, Inc., 1996.
   Google Scholar
• Bell IR, Ross J III, Gilbert Me, et al. Testing the neural sensitization and kind-ling hypothesis for illness from low levels of environmental chemicals. Environ Health Perspect, 1997; 105: 539–547.
   PubMed Web of Science ®Google Scholar